Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02151552 · ClinicalTrials.gov registry record · Early Phase 1
Assessing NOS Uptake With PET Imaging in Lung Inflammation
A Early Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 3
- Enrollment target
NCT02151552 is a Early Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 3 participants.
The verdict
NCT02151552, a Early Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to learn more about the basic responses of the lungs to inflammation using positron emission tomography, or PET, imaging scans of the lungs. PET is a machine that detects radiation and generates pictures using a donut-shaped scanner similar in appearance to an x-ray "CAT" or computed tomography (CT) scan or an MRI. Inflammation is the way our bodies react to irritation or injury, and involves red, warm, and often painful swelling of the affected tissue. An enzyme called inducible nitric oxide synthase (iNOS) contributes to the development of lung inflammation.
Interventions
- DRUG Endotoxin (E. coli O:113, Reference Endotoxin)
- DRUG [18F](+/-)NOS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-05 |
| Est. Completion | 2018-02 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02151552
The ClinicalTrials.gov registry entry for NCT02151552 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Endotoxin (E. coli O:113, Reference Endotoxin) is the first listed.
NCT02151552 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02151552 about?
NCT02151552 is a clinical study titled "Assessing NOS Uptake With PET Imaging in Lung Inflammation". The purpose of this study is to learn more about the basic responses of the lungs to inflammation using positron emission tomography, or PET, imaging scans of the lungs. PET is a machine that detects radiation and generates pictures using a donut-shaped scanner similar in appearance to an x-ray "CAT...
What is the current status of trial NCT02151552?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 3 participants. The study started on 2014-05. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02151552?
The interventions under investigation include: Endotoxin (E. coli O:113, Reference Endotoxin) (DRUG), [18F](+/-)NOS (DRUG).
Who is sponsoring clinical trial NCT02151552?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.